SC 13G/A

AMENDMENT NO. 2 TO THE SCHEDULE 13G

Company: Eledon Pharmaceuticals, Inc.
Filed: December 28, 2020
Accession Number: 0000921895-20-003279

View Document ↗ View on SEC.gov ↗